Michael Thomas Henderson
Director; Director, Chief Executive Officer · 14 filings · Latest: Sep 3, 2026
Apogee Therapeutics, Inc.
Spyre Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APGE | HENDERSON MICHAEL THOMAS | — | Dec 4, 2024 | Proposed Sale | $46.58 | 15,000 | $698.7K | — | |
APGE | HENDERSON MICHAEL THOMAS | — | Nov 6, 2024 | Proposed Sale | $59.23 | 15,000 | $888.4K | — | |
APGE | HENDERSON MICHAEL THOMAS | — | Oct 2, 2024 | Proposed Sale | $56.23 | 40,000 | $2.2M | — | |
APGE | HENDERSON MICHAEL THOMAS | — | Sep 4, 2024 | Proposed Sale | $47.62 | 40,000 | $1.9M | — |
← Previous
Page 2 of 2